In honor of ALS Awareness Month, the U.S. National ALS Registry is calling on individuals living with amyotrophic lateral sclerosis (ALS) to enroll and contribute to critical research. Every year, more than 5,000 Americans are diagnosed with ALS, a progressive neurodegenerative disease that affects nerve cells controlling muscle movement, leading to weakness and paralysis. Despite its impact, the exact causes of most ALS cases remain unknown, a gap the registry aims to close.
Dr. Paul Mehta, principal investigator of the National ALS Registry, emphasized the program's collaborative nature: "The National ALS Registry is a program of, by and for those living with ALS. The program collects, manages and analyzes data about people with ALS in the United States." The registry relies on voluntary participation from individuals who choose to register and complete risk factor surveys covering topics such as occupational history and environmental exposures.
The primary purpose of the registry is to gather data that can be used to estimate the number of new ALS cases each year, understand who gets the disease and what factors affect it, and enhance research to improve care for people with ALS. Since 2010, the registry has funded over a dozen studies exploring potential risk factors, using data to identify disease pattern changes and commonalities among patients.
Participation involves completing up to 18 risk factor surveys, which help create a more complete picture of each individual's ALS story. By sharing their experiences, enrollees directly support research that could benefit future generations. The registry is open to anyone living with ALS in the United States.
To enroll or learn more, visit the official website at cdc.gov/als. The initiative underscores the importance of patient-driven data in the fight against ALS, offering hope for better understanding and eventual treatment of this devastating disease.
As ALS Awareness Month continues, the registry's call to action highlights the critical role that individuals with ALS play in advancing research. Their contributions could help unlock answers about the disease's origins and pave the way for improved care and therapies.
